Anmeldung erfolgt in Kürze...
Details werden geladen...
Centre To Cap Trade Margins At 30 Per Cent Of MRP For 110 Anti-Cancer Drugs, Including 35 Patented Medicines
The Centre has capped trade margins at 30% for 110 non-scheduled anti-cancer medicines, with some MRPs potentially falling by up to 70%. The measure covers branded, generic, domestic and imported drugs and is expected to save patients around Rs 2,500 crore annually. It follows Supreme Court concerns over steep mark-ups on cancer medicines.
Ähnliche Seiten
Centre to cap trade margins at 30% for non-scheduled anti-cancer drugs - The Tribune
https://www.tribuneindia.com/news/india/centre-to-cap-trade-margins-at-30-for-non-scheduled-anti-cancer-drugs/
Centre plans 30% trade-margin cap on non-scheduled cancer drugs | Mint
https://www.livemint.com/industry/centre-plans-30-trade-margin-cap-on-non-scheduled-cancer-drugs-11791462383407.html
Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30% - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/govt-prepares-to-cap-anti-cancer-drugs-trade-margins-at-30-of-mrp/articleshow/134795010.cms
Cancer drug prices to drop as govt caps trade margin at 30pc - Rediff.com India News
https://www.rediff.com/news/report/cancer-drug-prices-to-drop-as-govt-caps-trade-margin-at-30pc/20261008.htm